Login

POET Technologies CEO Dr. Suresh Venkatesan is a global technology leader who has introduced the innovative POET Optical Interposer to the marketplace|Dr. Suresh Venkatesan ,CEO,POET Technologies 00:10:00

Share On Facebook Share On Twitter

Suresh is an industry veteran with over 22 years of experience in semiconductor technology development. Prior to joining GLOBALFOUNDRIES, he held various leadership positions with Freescale Semiconductor in Austin, Texas. Dr. Venkatesan holds over 25 US patents, and has co-authored over 50 technical papers. 

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Protecting Your Retirement: Essential Steps After a Layoff | Lindsay Adams, Advisor, CGN Advisors, LLC.
00:10:00
Forsee Power Aims for €100M: CEO Christophe Gurtner Discusses Smart Batteries and Market Strategy |Christophe Gurtner,CEO , Forsee Power SA.
00:10:00
Market Intelligence: Emerging Trends in the Fintech Sector | John Doerr, Chairman,  Kleiner Perkins.
00:10:00
Early Stages of Commercial Real Estate Reset Concerns.
00:10:00
Dynamic Mining Showcases Low-Capex Guinea Bauxite Project at One-to-One Conference
00:10:00
Marc Halbfinger, CEO of PCCW Global, speaks on ongoing developments at the Industrial and Commercial Bank of China Limited.
00:10:00
Datacolor: Your Partner in Precision Color Control | Albert Busch , PRESIDENT & CEO of Datacolor
00:10:00
Forging a More Perfect Union: A Journey of Community and Service|Lt. Col. Alphanso Adams
00:10:00
8990 Holdings Inc confident of double-digit growth with housing production on track to recovery|Anthony Vincent Sotto ,CEO,8990 Holdings Inc
00:10:00
"PagerDuty CEO Jennifer Tejada reports 33% revenue growth, noting the ongoing challenges of the macro environment."|Jennifer Tejada is the Chairperson and CEO of PagerDuty
00:10:00
Tapping into the collective consciousness to understand the future of our cities|Zach Aarons,Co-Founder and General Partner,MetaProp
00:10:00
Phase 2a Trial of CER-001 for Septic Patients and Future Biotech Meetings | Cyrille Tupin, CEO, Abionyx Pharma SA .

© 2017 - Townhall + Tv